Las Vegas Sun

Otsuka Reports Positive Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Prevented Progression to Kidney Failure and Improved Kidney ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

The FDA Just Approved a KEYTRUDA Combination That Could Become the Standard First-Line Treatment for Aggressive Breast Cancer

Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc.

Idaho is first to use firing squads as primary state execution method

Idaho will use firing squads as its primary method of capital punishment, the first state in the United States to officially ...

Is Viking Therapeutics stock going to $100?

That would be an impressive run if it could get there soon.

GLP-1 Analogues Market Analysis 2025-2029 | Expanding Indications and Multi-Agonist Therapies Drive GLP-1 Analogues Market Growth

The "Glp 1 Analogues Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The global GLP-1 analogues market is projected to expand significantly, with an estimated growth of USD 100.

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...